SCHEMBL20909568

SCHEMBL20909568

CC(F)(F)C1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22413663 0.77
SCHEMBL1447713 0.73
SCHEMBL846531 0.73
SCHEMBL30951905 0.71 SYK (0.30)
SCHEMBL12224296 0.69 LIPA (0.32)
SCHEMBL6410197 0.69
SCHEMBL24051086 0.69
SCHEMBL23784880 0.69
SCHEMBL17999779 0.69 EPHX1 (0.31)
SCHEMBL23784975 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066292-A1 TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海济煜医药科技有限公司 2023-04-27 WO disclosed
EP-3694858-B1 BICYCLIC COMPOUNDS FOR USE AS RIP1 KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2023-01-11 EP disclosed
EP-3875452-A1 MONOACYLGLYCEROL LIPASE INHIBITORS Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis (NL) 2021-09-08 EP disclosed
WO-2019072942-A1 BICYCLIC COMPOUNDS FOR USE AS RIP1 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-04-18 WO disclosed